Transcript rafael-gual

The role of the Pharmaceutical Industry
in the National Development Plan
Rafael Gual
Director General
CANIFARMA
October 2015
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
1
Pharma Industry;
facts & figures
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
2
Pharma Industry; facts & figures
 13º world market
 2nd Latinamerican market
 2013 Sales: 14.5 bDlls (ex-Factory prices)
 Nominal annual growth: 3.9%*
*II Compendio estadístico de la Industria Farmacéutica 2014.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
3
Pharma Industry; facts & figures
Sales in values
Total ex Factory sales all specialties (million pesos)
Sales
2007
2008
2009
2010
2011
2012
2013
2014e
150,611
154,927
162,778
170,829
179,266
186,573
193,899
203,594
Variation
%
2.9%
5.1%
4.9%
4.9%
4.1%
3.9%
250,000
6%
200,000
4%
5%
2%
150,000
100,000
50,000
0%
Ventas
-2%
% de variación
-4%
-
-6%
2007
2008
2009
2010
2011
2012
2013
2014e
Source: II Compendio Estadístico de la IF
*Values without inflation
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
4
Pharma Industry; facts & figures
 3.4 % Manufacturing Domestic Product
 0.6 % Gross Domestic Product*
 Investment 2013: 2.7 bDlls (18.3% / sales)
 Investment 2007 - 2013:
15.4 bDlls**
* INEGI. Sistema de cuentas nacionales de México
**II Compendio estadístico de la Industria Farmacéutica, CANIFARMA 2014
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
5
Pharma Industry; facts & figures
GDP of the Pharmaceutical Industry 2001-2014
2008 Peso value without inflation
Fuente: Elaboración IIIFAC con información del Sistema de Cuentas Nacionales, INEGI.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
Pharma Industry; facts & figures
Inversión Total
de todas
las especialidades
investment
(million(Millones
pesos)de pesos)
2007
2008
2009
2010
2011
2012
2013
2014e
Inversión
22,825
24,954
27,751
27,538
28,832
33,466
35,408
36,903
% de las ventas
15.2%
16.1%
17.0%
16.1%
16.1%
17.9%
18.3%
18.1%
* Notas: Valores en pesos corrientes.
Los datos de ventas estimadas proceden de los porcentajes de crecimiento declarados por las empresas.
Fuente: II Compendio estadístico de la Industria Farmacéutica en México, CANIFARMA.
16.1%
11.2%
9.3%
5.8%
4.7%
4.2%
Inversión
% de variación
-0.8%
2007
2008
2009
2010
2011
2012
2013
2014e
* Nota: Los datos de ventas estimadas proceden de los porcentajes de crecimiento declarados por las empresas.
Fuente: II Compendio estadístico de la Industria Farmacéutica en México, CANIFARMA.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
7
Pharma Industry; facts & figures
 16.7% of total investment in R&D
 In 2013: 378 mDlls*
a. 4% Basic Research
b. 76% Clinical Research
c. 20% Technological development
*II Compendio estadístico de la Industria Farmacéutica, CANIFARMA 2014
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
8
Pharma Industry; facts & figures
Research & development
R&D investment
(million pesos)
2007
2008
2009
2010
2011
2012
2013
R&D
2,703
2,777
3,213
3,855
4,638
4,676
5,025
% of
Total
Investment
13.2%
12.7%
13.3%
15.6%
17.1%
15.8%
16.7%
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
9
Pharma Industry; facts & figures
 3,765 millions of units (installed capacity)
 60.8% utilized capacity
 90.3% national requirements
 83.4% national manufacturing
 90% with manufacturing facilities
*II Compendio estadístico de la Industria Farmacéutica, CANIFARMA 2014
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
10
Pharma Industry; facts & figures
2013 Exports: $1.03 bDlls
2007 – 2013: increased by 65.1%
Exports of
generation
Export markets:
medicines
mainly
and
income
47.9% South America
23.5% Europe
18.1% Central America
An important development potential
*II Compendio de la Industria Farmacéutica, CANIFARMA 2014
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
11
The Pharmaceutical Industry
Development Program and
Sector Plans
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
12
The Development Program
 Pharmaceutical Industry Development
Program
 Designed in accordance to National
Development Plan
a. Following five presidential goals
b. Defining times & actors
c. Common industry-government goals
d. The patient as our main priority
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
13
The Development Program
Line 1. Sanitary regulatory framework
To foster and improve the sanitary regulatory framework
Line 2. Research, technological development & innovation
To turn Mexico into the center of technological development of the
pharmaceutical industry in Latin America and become the leader in
basic and clinical research
Line 3. Industrial policy
To become a pillar of the economy and an industrial model with high
agregated value and articulation with other sectors
Line 4. Health rights
To foster the contribution of the pharma industry to the health
protection rights
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
14
The Development Program
 The industrial policy of the ministry of Economy has considered 15
priority sectors. The Pharma Industry has been considered an
emerging sector along with Medical devices and Biotech.
SECTORES
MADUROS
- Metal mecánico
- Textil vestido y cuero
calzado
- Madera y muebles
- Siderúrgico
- Alimentos y bebidas
Impulsar la Productividad
SECTORES
DINÁMICOS
- Automotriz y
Autopartes
- Aeroespacial
- Eléctrico
- Electrónico
- Químico
Incrementar la
Competitividad
The role of the Pharmaceutical Industry in the National Development Plan
SECTORES
EMERGENTES
- Biotecnología
- Farmacéutico
- TI
- Industrias Creativas
- Dispositivos Médicos
Atraer y fomentar los
sectores emergentes
RRGC
The Development Program
A better regulatory framework
Agile procedures
Backlog reduction
Legal certainty
Purposeful interaction with
authorities
 Cooperation spirit between I&G





The role of the Pharmaceutical Industry in the National Development Plan
RRGC
16
Strategic participation
Strategic participation of Industry
in the development of Mexico’s
Health and Economy
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
17
Strategic participation
 In recent years the promotion policy of generics has
allowed advancement in the goal of access:
 "The Government policy of generics as achieved a
reduction... of 61% in prices... which represents an
average saving of $1,047 pesos, from $1,652 to $605
pesos“
 Mexicans reduced "... their expenditure on drugs as a
percentage of total expenditure on health from
32.2% in 2010 to 28% in 2013..." Similarly,... drug
expenditure as a percentage of GDP decreased from
2% to 1.73% "
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
18
Strategic participation
 Public policy actions should be focused on tackling the
problems diagnosed by the 2013-2018 Health Sector
Program
a. Public expenditure on health (47.3%)
OCDE (72.2%)
b. NHS administrative expenditure (10%)
OCDE (4%)
c. Configuration of NHS is heterogeneous and disarticulated
 As a consequence access to health services and drugs
is obstaculized.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
19
Strategic participation
National economy and health
A country’s productivity is based upon three resources:
people, physical capital and natural resources. Health plays a
Paramount role for people to maximize their economical
potential since:
“An inefficient or underfunded health system prevents a
country from aspiring to the highest level of growth and
competitivity. The cost of this inefficiency has an impact on
companies, work productivity and families”.*
*Felicia Knaul, Héctor Arreola, Christian Borja, et. al. Competitividad y Salud: la
propuesta. Fundación Mexicana para la Salud, México, 2003, p. 6.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
20
Strategic participation
 2013-2018 Health Sector Program:
 Optimization of NHS functions
 The idea that the resources dedicated to providing
health services are an investment on the country
itself must underlie the center of the national
agenda in the short, medium and long terms.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
21
Strategic participation
 In order to face the health challenges ahead, it is
indispensable to design public policies that optimize
investments on health.
 This is one of the main challenges for the NHS, and it
requires the participation of all involved actors so as
to design and implement collective actions to build a
viable universal health system today, in 2015.
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
22
The role of the Pharmaceutical Industry
in the National Development Plan
THANK YOU
[email protected]
The role of the Pharmaceutical Industry in the National Development Plan
RRGC
23